News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
818,574 Results
Type
Article (85134)
Company Profile (690)
Press Release (732750)
Section
Business (231011)
Career Advice (4096)
Deals (39605)
Drug Delivery (112)
Drug Development (90205)
Employer Resources (194)
FDA (17760)
Job Trends (17250)
News (393267)
Policy (39557)
Tag
Academia (2968)
Alliances (56152)
Alzheimer's disease (1185)
Antibody-drug conjugate (ADC) (61)
Approvals (17709)
Artificial intelligence (62)
Bankruptcy (393)
Best Places to Work (12104)
Biosimilars (56)
Biotechnology (460)
Cancer (176)
Career advice (3501)
Cell therapy (87)
Clinical research (69661)
COVID-19 (2713)
Cystic fibrosis (72)
Diagnostics (6407)
Diversity, equity & inclusion (48)
Drug pricing (64)
Earnings (92435)
Employer resources (163)
Events (123873)
FDA (17761)
Featured Employer (72)
Gene therapy (77)
GLP-1 (580)
Government (4978)
Healthcare (20533)
Infectious disease (2725)
Inflammatory bowel disease (93)
Interviews (806)
IPO (17387)
Job creations (5173)
Job search strategy (2852)
Layoffs (459)
Legal (9981)
Liver cancer (56)
Lung cancer (45)
Management (61)
Manufacturing (66)
Medical device (14150)
Medtech (14153)
Mergers & acquisitions (21858)
Metabolic disorders (191)
Neuroscience (1283)
NextGen: Class of 2025 (7626)
Non-profit (5033)
Northern California (311)
Obesity (131)
Opinion (221)
People (63254)
Pharmaceutical (135)
Phase I (21395)
Phase II (30247)
Phase III (22875)
Podcasts (88)
Policy (53)
Postmarket research (3531)
Preclinical (9706)
Press Release (72)
Radiopharmaceuticals (202)
Rare diseases (103)
Real estate (7356)
Recruiting (74)
Regulatory (25367)
Research institute (2627)
Resumes & cover letters (645)
Southern California (330)
Startups (4257)
The Weekly (50)
United States (5116)
Vaccines (497)
Weight loss (143)
Date
Today (5)
Last 7 days (20)
Last 30 days (49)
Last 365 days (20584)
2025 (35)
2024 (22210)
2023 (42567)
2022 (53928)
2021 (58724)
2020 (57670)
2019 (51341)
2018 (39125)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1259)
Arizona (189)
Asia (48660)
Australia (8556)
California (776)
Canada (557)
Europe (111224)
Florida (57)
Idaho (62)
Illinois (244)
Indiana (114)
Kansas (97)
Maine (51)
Maryland (262)
Massachusetts (966)
Michigan (98)
Minnesota (189)
New Jersey (303)
New York (249)
North Carolina (578)
Northern California (311)
Ohio (70)
Pennsylvania (344)
South America (1640)
Southern California (330)
Texas (88)
Washington State (213)
818,574 Results for "biospace".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
BioSpace
Announces 2025 Best Places to Work in Biopharma
BioSpace
has named 50 biopharma companies to its 2025 Best Places to Work list, including Moderna and Sutro Biopharma, whose executives share what makes their organizations special.
November 12, 2024
·
6 min read
·
Angela Gabriel
NextGen
BioSpace
’s NextGen Class of 2025 Leans Into Biopharma’s Hottest Trends
From ADCs and radiopharmaceuticals to cell and gene therapies, eager young startups are betting on advances in biopharma’s most competitive therapeutic spaces—and attracting dollars from Big Pharma.
January 7, 2025
·
4 min read
·
Heather McKenzie
Policy
BioSpace at #DIA2024: Convergence and Collaboration
BioSpace’s Lori Ellis and Chantal Dresner bring live updates from the first day of #DIA2024 in San Diego.
June 17, 2024
·
1 min read
Job Trends
California Tops Biopharma Job Openings So Far in 2024, Per
BioSpace
Data
For the first eight months of 2024, California had the most job postings live on
BioSpace
—37.7% more than Massachusetts. Last year, Massachusetts ranked No.1 for the same time period.
September 12, 2024
·
4 min read
·
Angela Gabriel
Layoff Tracker
Apellis, Barinthus, Repare Among Latest to Trim Workforces
2024 was a tough year for the biopharma industry, with several companies cutting hundreds or even thousands of employees. Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
January 14, 2025
·
103 min read
·
BioSpace Editorial Staff
BioSpace at #DIA2024: Workforce Trends, Trial Design, Peter Marks & Recap
BioSpace’s Lori Ellis and Chantal Dresner bring live updates from day three of #DIA2024 in San Diego.
June 20, 2024
·
1 min read
Drug Development
BioSpace x DIA: Navigating the Emergence of CGT Combination Products
BioSpace’s Lori Ellis discusses the risks and challenges of cell and gene therapy combination products with DIA speakers James Wabby, AbbVie and Rob Schulz, Suttons Creek, Inc.
May 22, 2024
·
1 min read
·
Lori Ellis
Business
A Conversation with Peter Marks and Tom Whitehead: Insights into GenScript Biotech Forum 2025 (Teaser)
In this short teaser, BioSpace’s Head of Insights Lori Ellis talks to CBER Director Peter Marks and Tom Whitehead, Co-Founder of the Emily Whitehead Foundation about anticipated discussions at the upcoming GenScript Biotech Forum.
January 10, 2025
·
1 min read
·
Lori Ellis
Press Releases
Catalyst Pharmaceuticals Recognized Among BioSpace 2025 Best Places to Work
November 14, 2024
·
3 min read
BioSpace x DIA: Robust Integrated Regulatory Strategies
How do we ensure strategic vision and thoughtful implementation when pursuing new opportunities in science and technology? Our guests discuss challenges around reimbursement, intellectual property, change management and the critical nature of early engagement.
June 5, 2024
·
1 min read
1 of 81,858
Next
